Skip to main content

Table 1 Demographic and clinical data for the study population

From: Two-dimensional speckle-tracking echocardiography for evaluation of dilative ascending aorta biomechanics

Parameter

Controls

Diameter of ascending aorta

p

Group 1 (≤45 mm)

Group 2 (>45 mm)

Controls vs. group 1

Controls vs. group 2

Group 1 vs. group 2

Age (years)

58.2 ± 7.1

52.9 ± 13.8

60.1 ± 12.2

NS

NS

NS

Sex (F/M) (%)

43.3/56.7

18.8/81.2

25.0/75.0

NS

NS

NS

Body surface area (m2)

1.91 ± 0.2

2.01 ± 0.2

2.0 ± 0.2

NS

NS

NS

Arterial hypertension (%)

65.2

60.0

89.3

NS

0.02

0.02

Blood pressure (mmHg)

 Systolic

134.6 ± 13.7

138.8 ± 17.7

145.8 ± 23.5

NS

0.01

NS

 Diastolic

84.1 ± 9.6

73.4 ± 13.0

78.8 ± 11.8

0.003

0.03

NS

Antihypertensive Rx (%)

 β-Blockers

25.5

85.7

77.8

<0.05

0.001

NS

 ACE-I

22.0

64.3

55.6

<0.05

0.002

NS

 ARB

17.6

7.7

18.5

NS

NS

NS

Smokers (%)

28.8

0

7.4

<0.05

0.02

NS

Aortic valve pathology (%)

 Aortic valve insufficiency

0

50.0

53.8

<0.001

<0.001

NS

 Stenosis

0

6.2

15.4

NS

0.002

NS

 Bicuspid

0

62.5

30.4

0.001

0.001

0.04

  1. ACE-I angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers, NS not significant, Rx treatment, Values are mean (SD) unless otherwise indicated